Cite
HARVARD Citation
Kingsbury, D. et al. (2013). SAT0436 Safety and Effectiveness of Adalimumab in Children with Polyarticular Juvenile Idiopathic Arthritis Aged 2 To <4 Years or ≥4 Years Weighing <15 KG. Annals of the rheumatic diseases. p. A729. [Online].